Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$158,271,860
+$7,597,050 QoQ
Shares Held
15,827,186
0.0% QoQ
Ownership
6.19%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
#2
of 316 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $199,243,952 across 2 Drug Manufacturers - Specialty & Generic names. BCRX ranks #1 (79.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
15,827,186 | $158,271,860 | |
| 2 | BIOA |
BioAge Labs, Inc.
|
1,671,648 | $40,972,092 |
All Filings in BCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $158,271,860 | 15,827,186 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $158,271,860 | 15,827,186 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $150,674,810 | 15,827,186 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $123,452,050 | 15,827,186 | Shares | Sole | 2026-02-17 | |
| 2025-11-04 | $103,442,777 | 15,302,186 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||